Cure SMA is committed to supporting healthcare providers. Our educational programs aim to serve as a resource for clinicians and ensure the availability of useful, timely, and accurate information about spinal muscular atrophy (SMA).

Enduring CME Events

Best Practices in the Care of Adult Patients with Spinal Muscular Atrophy

Credits Available:

Physiciansmaximum of 0.50 AMA PRA Category 1 Credit(s)™

ABIM Diplomates – maximum of 0.50 ABIM MOC points

Nurses – 0.50 ANCC Contact Hour(s) (0.25 contact hours are in the area of pharmacology)

IPCE – 0.25 Interprofessional Continuing Education (IPCE) credit

Estimated Time to Complete Activity: 30 minutes

Available through January 20, 2024.

Start Activity


Current State of Therapeutics in Spinal Muscular Atrophy:  A Guide to Holistic Management

Credits Available:

Physiciansmaximum of 0.50 AMA PRA Category 1 Credit(s)™

ABIM Diplomates – maximum of 0.50 ABIM MOC points

Estimated Time to Complete Activity: 30 minutes

Available through May 13, 2023.

Start Activity




Treatment Decisions in Spinal Muscular Atrophy:  Best Practices in Adolescent and Adult Patients

Credits Available:

Physicians – 0.50 AMA PRA Category 1 Credit™

ABIM Diplomates – 0.50 ABIM MOC points

Estimated Time to Complete Activity: 30 minutes

Available through March 2023.

Start Activity




Skeletal Health for Children with SMA: An Update in the Era of Pharmacological Therapy

Credits Available:

Physicians – 0.50 AMA PRA Category 1 Credit™

ABIM Diplomates – 0.50 ABIM MOC points

Estimated Time to Complete Activity: 30 minutes

Available through March 2023.

Start Activity




Adolescent and Adult Spinal Muscular Atrophy: Perspectives on Diagnosis and Disease Burden

Credits Available:

Physicians – maximum of 0.50 AMA PRA Category 1 Credit(s)™

ABIM Diplomates – maximum of 0.50 ABIM MOC points

Nurses – 0.50 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

Estimated Time to Complete Activity: 30 minutes

Available through January 2023.

Start Activity








SMArt Moves Resource

Developmental delays can be early signs of a serious medical condition. Cure SMA created the SMArt Moves campaign to educate parents and healthcare providers about the signs of delayed milestones. With SMA, early diagnosis and early treatment is key. Visit to the SMArt Moves HubSpot for healthcare providers for additional opportunities for credit, non-credit educational activities, a provider toolkit, and more.

smartmoves hub spot


Virtual Live CME Events

While there are currently no live CME events to promote, any future events will be published here for you to register and learn more.

Non-Credit Opportunities

Cure SMA has partnered with PlatformQ and NORD to develop 4 modules around SMA treatment decisions in SMA. These modules showcase the perspective of an adult with SMA. Modules are available through July 2022.

Treatment and Post‐treatment Decisions in SMA: What it Looks Like for Patients, Caregivers, and Families

Cure SMA partnered with NeurologyLive and HCPLive to develop a video series entitled “Evaluation of Spinal Muscular Atrophy in the Era of Telehealth”. The goal of this partnership is to enhance current awareness and understanding of SMA diagnostic requirements, while demonstrating opportunities to screen and evaluate suspected SMA in a remote appointment setting.

Primary Care Providers, Visit HCPLive!
Child Neurologists, Neuromuscular Specialists, and PTs, Visit NeurologyLive!

Cure SMA has partnered with Platform Q to develop six modules surrounding support and care for children with SMA after gene replacement therapy. These modules showcase the family perspective on gene therapy and multidisciplinary care for SMA. Modules are available through September 2021.

Visit Neurocare Live

Cure SMA’s Virtual Summit of Strength Webinars and 2020 Virtual SMA Conference Webinars provide a variety of educational topics for SMA. These are posted on our YouTube channel and available to the public. There is no CE/CME credit associated with these videos.

Visit our YouTube Channel

In 2016, experts in SMA care met to present and discuss the latest discoveries and options for optimizing care. The meeting was organized by The University of Pennsylvania’s Penn Medicine and was co-sponsored by  Novartis Gene Therapies (formerly AveXis) and the Orphan Disease Center.

Visit our SoundCloud page